Download
Disease/health condition -
Influenza A and B infection
Influenza A and B nucleic acid amplification test
Assay format
Low-complexity automated NAAT
Information History
First added in 2019
Changed in 2024
Purpose type
Diagnosis
Purpose
To diagnose seasonal influenza infection in patients with suspected non-severe influenza virus infection who are at high risk of progression to severe influenza (patients 65 years and older; patients with one or more major risk factors for developing severe influenza).
Specimen types
Upper respiratory specimens (e.g., Nasal swab, Nasopharyngeal swab, Nasopharyngeal aspirate or wash)
WHO prequalified or recommended products
N/A
GMDN
47277
Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT)
Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT)
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024EMDN
W0105040504
INFLUENZA & PARA INFLUENZA - NA REAGENTS
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdnWHO supporting publications
World Health Organization. (2024). Clinical practice guidelines for influenza. World Health Organization. https://iris.who.int/handle/10665/378872
Technical specifications
This tool includes 1 technical specification for Influenza A and B nucleic acid amplification test listed in the EDL. To review it, download the file and go to the “Test menu” tab to make your selection.
Related Medical Devices in MeDevIS
SAGE IVD recommended including this test in the EDL on the basis of the scientific validity of the analyte and the availability of WHO guidelines and technical reports, including recommendations for the use of this test. The selection of disease specific tests for the EDL also took into account relevant priority diseases for WHO such as NCDs including DM, CVD and cancer, HIV infection, malaria, NTDs, STIs, tuberculosis, viral hepatitis B and C, among others.
N/A
The inclusion of this test was based on WHO guidelines and/or technical documents that include recommendations for the use of this test.
N/A